Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT01839097 · COMPLETED
Trial details
- NCT number
- NCT01839097
- Sponsor
- Acrotech Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.